1-5 of 5
Axel Heidenreich
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study

Open Access
Gazanfer Belge, Cansu Dumlupinar, Tim Nestler, Markus Klemke, Peter Törzsök, Emanuela Trenti, Renate Pichler, Wolfgang Loidl, Yue Che, Andreas Hiester, Cord Matthies, Martin Pichler, Pia Paffenholz, Luis Kluth, Mike Wenzel, Jörg Sommer, Julia Heinzelbecker, Philipp Schriefer, Alexander Winter, Friedemann Zengerling, Mario Wolfgang Kramer, Marie Lengert, Jana Frey, Axel Heidenreich, Christian Wülfing, Arlo Radtke, Klaus-Peter Dieckmann
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (2): 404–412.
https://doi.org/10.1158/1078-0432.CCR-23-0730
Published: 17 January 2024
View articletitled, Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study
Open the PDF for Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study in another window
Includes: Supplementary data
Journal Articles

Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer

Available to Purchase
Aurelius Omlin, Richard Cathomas, Gunhild von Amsberg, Christoph Reuter, Susan Feyerabend, Wolfgang Loidl, Martin Boegemann, Anja Lorch, Axel Heidenreich, Igor Tsaur, Julian Larcher-Senn, Stefan A.J. Buck, Ron H.J. Mathijssen, Ulrich Jaehde, Silke Gillessen, Markus Joerger
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (10): 1887–1893.
https://doi.org/10.1158/1078-0432.CCR-22-3360
Published: 15 May 2023
View articletitled, Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer
Open the PDF for Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Response to Rucaparib in BRCA-Mutant Metastatic Castration-Resistant Prostate Cancer Identified by Genomic Testing in the TRITON2 Study

Free
Andrea Loehr, Akash Patnaik, David Campbell, Jeremy Shapiro, Alan H. Bryce, Ray McDermott, Brieuc Sautois, Nicholas J. Vogelzang, Richard M. Bambury, Eric Voog, Jingsong Zhang, Josep M. Piulats, Arif Hussain, Charles J. Ryan, Axel S. Merseburger, Gedske Daugaard, Axel Heidenreich, Karim Fizazi, Celestia S. Higano, Laurence E. Krieger, Cora N. Sternberg, Simon P. Watkins, Darrin Despain, Andrew D. Simmons, Melanie Dowson, Tony Golsorkhi, Simon Chowdhury, Wassim Abida
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (24): 6677–6686.
https://doi.org/10.1158/1078-0432.CCR-21-2199
Published: 15 December 2021
View articletitled, Response to Rucaparib in BRCA-Mutant Metastatic Castration-Resistant Prostate Cancer Identified by Genomic Testing in the TRITON2 Study
Open the PDF for Response to Rucaparib in BRCA-Mutant Metastatic Castration-Resistant Prostate Cancer Identified by Genomic Testing in the TRITON2 Study in another window
Includes: Supplementary data
Journal Articles

Genetic Pathways and New Progression Markers for Prostate Cancer Suggested by Microsatellite Allelotyping

Free
Rolf von Knobloch, Lutz Konrad, Peter J. Barth, Heidrun Brandt, Sebastian Wille, Axel Heidenreich, Roland Moll, Rainer Hofmann
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (3): 1064–1073.
https://doi.org/10.1158/1078-0432.CCR-03-0070
Published: 10 February 2004
View articletitled, Genetic Pathways and New Progression Markers for Prostate Cancer Suggested by Microsatellite Allelotyping
Open the PDF for Genetic Pathways and New Progression Markers for Prostate Cancer Suggested by Microsatellite Allelotyping in another window
Journal Articles

Molecular Serological Detection of DNA Alterations in Transitional Cell Carcinoma Is Highly Sensitive and Stage Independent

Free
Rolf von Knobloch, Heidrun Brandt, Andres J. Schrader, Axel Heidenreich, Rainer Hofmann
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (3): 988–993.
https://doi.org/10.1158/1078-0432.CCR-0851-3
Published: 10 February 2004
View articletitled, Molecular Serological Detection of DNA Alterations in Transitional Cell Carcinoma Is Highly Sensitive and Stage Independent
Open the PDF for Molecular Serological Detection of DNA Alterations in Transitional Cell Carcinoma Is Highly Sensitive and Stage Independent in another window